Fierce Biotech February 16, 2024
As a graduate student at the University of California, Los Angeles, Negin Majedi, Ph.D., developed an implantable, spongelike device that may treat solid tumors with fewer side effects than other immunotherapies. Thanks to a new award, its efficacy will be studied in space.
Majedi is the CEO of Symphony Biosciences, a startup built around SymphNode, the immunotherapy device she invented. Her company is one of two new recipients of the Technology in Space Prize, an award sponsored by airline giant Boeing and the Center for the Advancement of Science in Space, the operator of the International Space Station. Symphony and a second startup, FluxWorks, will together receive more than $630,000 total to carry out experiments aboard the ISS—the kind of...
Today's Sponsors
Today's Sponsor